Evidence map›Paper›PMID 40867287›Full record

ArticleCancers2025

Prognostic Impact of the AML60+ Score for Elderly Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents: A Retrospective Multicentric Analysis.

Verena Petermichl, Stefan Fuchs, Matthias Weber, Katrin Gobat, Charlotte Micheloud, Lukas Graf, Yannick Gerth, Jeroen S Goede, Thomas Lehmann, Christoph Driessen and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Verena PetermichlClinic for Medical Oncology and Hematology, Cantonal Hospital St. Gallen, 9007 St. Gallen, Switzerland.
Stefan FuchsDepartment of Internal Medicine, Cantonal Hospital Graubünden, 7000 Chur, Switzerland.
Matthias WeberInstitute of Pathology, Cantonal Hospital St. Gallen, 9007 St. Gallen, Switzerland.
Katrin GobatSwiss Cancer Institute, Statistics Unit, 3008 Bern, Switzerland.
Charlotte MicheloudSwiss Cancer Institute, Statistics Unit, 3008 Bern, Switzerland.ORCID 0000-0002-4995-4505
Lukas GrafCenter for Laboratory Medicine, St. Gallen, 9007 St. Gallen, Switzerland.
Yannick GerthCenter for Laboratory Medicine, St. Gallen, 9007 St. Gallen, Switzerland.
Jeroen S GoedeMedical Oncology and Hematology, Cantonal Hospital Winterthur, 8400 Winterthur, Switzerland.ORCID 0000-0001-7054-0174
Thomas LehmannClinic for Medical Oncology and Hematology, Cantonal Hospital St. Gallen, 9007 St. Gallen, Switzerland.
Christoph DriessenClinic for Medical Oncology and Hematology, Cantonal Hospital St. Gallen, 9007 St. Gallen, Switzerland.
Ulrich J M MeyDepartment of Medical Oncology and Hematology, Cantonal Hospital Graubünden, 7000 Chur, Switzerland.
Richard CathomasDepartment of Medical Oncology and Hematology, Cantonal Hospital Graubünden, 7000 Chur, Switzerland.ORCID 0000-0002-9677-9885
Sergio CogliattiInstitute of Pathology, Cantonal Hospital St. Gallen, 9007 St. Gallen, Switzerland.
Tobias SilzleClinic for Medical Oncology and Hematology, Cantonal Hospital St. Gallen, 9007 St. Gallen, Switzerland.ORCID 0000-0001-6859-3090

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute myeloid leukemiaAML60+ELN2022hypomethylating agentsmPRSprognosticationvenetoclax

Identifiers

PMID40867287
PMCPMC12384718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.